| NCT00055055 |
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders |
https://ClinicalTrials.gov/show/NCT00055055 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04454034 |
Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04454034 |
Enrolling by invitation |
Peking University Third Hospital |
2020-12-31 |
| NCT04434118 |
Hydroxychloroquine May Reduce Risk of COVID-19 Infection in Rheumatoid Arthritis Patients: |
https://ClinicalTrials.gov/show/NCT04434118 |
Enrolling by invitation |
Sadat City University |
2020-06-30 |
| NCT03763201 |
Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03763201 |
Recruiting |
Benha University |
2020-09-15 |
| NCT03378219 |
An Observational Study on Sarilumab-exposed Pregnancies |
https://ClinicalTrials.gov/show/NCT03378219 |
Recruiting |
Sanofi |
2027-08-31 |
| NCT03348046 |
Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan |
https://ClinicalTrials.gov/show/NCT03348046 |
Completed |
Hikma Pharmaceuticals LLC |
2019-04-14 |
| NCT03832374 |
Association Between Subtypes of Anti Citrullinated Peptide Antibodies and Lung Damage in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03832374 |
Recruiting |
University Hospital Center of Martinique |
2020-06-30 |
| NCT03449589 |
Effect of Smoking on Pain and Atherosclerosis in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03449589 |
Recruiting |
Vastra Gotaland Region |
2020-11-30 |
| NCT03339089 |
Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT03339089 |
Recruiting |
AbbVie |
2021-06-30 |
| NCT03331393 |
The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03331393 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-05-14 |
| NCT03294876 |
Rheumatoid Arthritis Adrenal Recovery Study |
https://ClinicalTrials.gov/show/NCT03294876 |
Recruiting |
University of Edinburgh |
2020-08-01 |
| NCT03291457 |
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice |
https://ClinicalTrials.gov/show/NCT03291457 |
Completed |
Hoffmann-La Roche |
2019-12-04 |
| NCT03288584 |
Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03288584 |
Recruiting |
University of Athens |
2020-12-31 |
| NCT03285191 |
Subject Insights to Understand Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT03285191 |
Completed |
GlaxoSmithKline |
2017-08-17 |
| NCT03277989 |
INFINITYâ„¢Total Ankle Replacement Follow-up |
https://ClinicalTrials.gov/show/NCT03277989 |
Recruiting |
Wright Medical Technology |
2030-10-31 |
| NCT03274141 |
Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC) |
https://ClinicalTrials.gov/show/NCT03274141 |
Completed |
Bristol-Myers Squibb |
2018-10-31 |
| NCT03270982 |
Comprehensive Segmental Revision System |
https://ClinicalTrials.gov/show/NCT03270982 |
Recruiting |
Zimmer Biomet |
2023-04-30 |
| NCT03267147 |
PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS |
https://ClinicalTrials.gov/show/NCT03267147 |
Active, not recruiting |
Fraunhofer Institute for Molecular Biology and Applied Ecology |
2021-04-30 |
| NCT03266822 |
T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy |
https://ClinicalTrials.gov/show/NCT03266822 |
Completed |
Szeged University |
2015-12-30 |
| NCT03264703 |
Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World |
https://ClinicalTrials.gov/show/NCT03264703 |
Completed |
Eisai Inc. |
2019-07-31 |
| NCT03249467 |
Validation of the French Version of the Health Assessment Questionnaire II (HAQ-II) for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03249467 |
Completed |
Rennes University Hospital |
2016-07-31 |
| NCT03223012 |
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service |
https://ClinicalTrials.gov/show/NCT03223012 |
Completed |
AbbVie |
2019-02-28 |
| NCT03190746 |
Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity |
https://ClinicalTrials.gov/show/NCT03190746 |
Completed |
Keesler Air Force Base Medical Center |
2017-06-01 |
| NCT03188081 |
A Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous (SC) Abatacept |
https://ClinicalTrials.gov/show/NCT03188081 |
Recruiting |
Bristol-Myers Squibb |
2019-08-04 |
| NCT03149796 |
Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT03149796 |
Completed |
Carmel Medical Center |
2013-05-01 |
| NCT03124225 |
Ultrasound Utility in Routine Clinical Practise |
https://ClinicalTrials.gov/show/NCT03124225 |
Completed |
Barts & The London NHS Trust |
2012-12-31 |
| NCT03112213 |
Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment |
https://ClinicalTrials.gov/show/NCT03112213 |
Completed |
Hoffmann-La Roche |
2018-07-17 |
| NCT03106259 |
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj |
https://ClinicalTrials.gov/show/NCT03106259 |
Active, not recruiting |
Kang Stem Biotech Co., Ltd. |
2017-01-24 |
| NCT03073109 |
Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions |
https://ClinicalTrials.gov/show/NCT03073109 |
Completed |
Pfizer |
2019-09-16 |
| NCT03063593 |
UK Infinity, Post-Market Clinical Follow-up Study |
https://ClinicalTrials.gov/show/NCT03063593 |
Active, not recruiting |
Wright Medical Technology |
2029-04-29 |
| NCT03006198 |
Tracking Biologics Along the Silk Road |
https://ClinicalTrials.gov/show/NCT03006198 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2018-12-01 |
| NCT02963402 |
Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab |
https://ClinicalTrials.gov/show/NCT02963402 |
Completed |
Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau |
2018-10-01 |
| NCT02932644 |
Vitamin D and Cardiovascular Events in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02932644 |
Completed |
Odense University Hospital |
2016-10-31 |
| NCT02930187 |
Ultrasound Evaluation of Remission in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02930187 |
Completed |
University Hospital, Grenoble |
2016-04-30 |
| NCT02927535 |
Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France |
https://ClinicalTrials.gov/show/NCT02927535 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2016-09-30 |
| NCT02927509 |
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France |
https://ClinicalTrials.gov/show/NCT02927509 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2016-09-30 |
| NCT02924623 |
Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity |
https://ClinicalTrials.gov/show/NCT02924623 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2018-03-01 |
| NCT02915094 |
Kineret in the Treatment of Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02915094 |
Completed |
Swedish Orphan Biovitrum |
2016-01-31 |
| NCT02905175 |
Rheumatoid Arthritis Patients and Porphyromonas Gingivalis |
https://ClinicalTrials.gov/show/NCT02905175 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2016-06-27 |
| NCT02897817 |
Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02897817 |
Completed |
Nordic Pharma SAS |
2017-12-31 |
| NCT02894047 |
Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years |
https://ClinicalTrials.gov/show/NCT02894047 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2015-10-31 |
| NCT02886689 |
C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France |
https://ClinicalTrials.gov/show/NCT02886689 |
Completed |
Central Hospital, Nancy, France |
2010-12-31 |
| NCT02885818 |
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02885818 |
Completed |
University Hospital, Brest |
2018-01-11 |
| NCT02863653 |
Participation Restrictions in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02863653 |
Completed |
Federal University of Minas Gerais |
2009-08-31 |
| NCT02809833 |
Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine |
https://ClinicalTrials.gov/show/NCT02809833 |
Completed |
Hoffmann-La Roche |
2012-03-31 |
| NCT02794012 |
Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02794012 |
Completed |
University of Colorado, Denver |
2017-12-31 |
| NCT02758769 |
Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings |
https://ClinicalTrials.gov/show/NCT02758769 |
Recruiting |
Bristol-Myers Squibb |
2023-09-30 |
| NCT02750800 |
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) |
https://ClinicalTrials.gov/show/NCT02750800 |
Completed |
AbbVie |
2018-04-03 |
| NCT02747277 |
Analysis of B Cells From Autoimmune Individuals |
https://ClinicalTrials.gov/show/NCT02747277 |
Recruiting |
University of Colorado, Denver |
2026-05-31 |
| NCT02730286 |
Activity Limitations in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02730286 |
Completed |
Federal University of Minas Gerais |
2009-08-31 |
| NCT02721004 |
Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02721004 |
Completed |
Hoffmann-La Roche |
2014-12-31 |
| NCT02699892 |
Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02699892 |
Completed |
Hoffmann-La Roche |
2014-02-28 |
| NCT02689115 |
NFKB1 and IKK Epsilon in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02689115 |
Completed |
Asociación CientÃfica Latina A.C. |
2014-06-30 |
| NCT02686320 |
Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65 |
https://ClinicalTrials.gov/show/NCT02686320 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2023-07-03 |
| NCT02679001 |
A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment. |
https://ClinicalTrials.gov/show/NCT02679001 |
Completed |
Hoffmann-La Roche |
2017-12-07 |
| NCT02668640 |
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China |
https://ClinicalTrials.gov/show/NCT02668640 |
Completed |
AbbVie |
2018-06-12 |
| NCT02675218 |
Bone MicroArchitecture Abatacept (BMA2) |
https://ClinicalTrials.gov/show/NCT02675218 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2020-03-31 |
| NCT02652299 |
Fibrocytes in Early and Longstanding Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02652299 |
Completed |
Odense University Hospital |
2018-04-04 |
| NCT02648035 |
EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02648035 |
Completed |
Hoffmann-La Roche |
2018-12-20 |
| NCT02641977 |
Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate |
https://ClinicalTrials.gov/show/NCT02641977 |
Completed |
Ruhr University of Bochum |
2016-04-30 |
| NCT02639988 |
Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years |
https://ClinicalTrials.gov/show/NCT02639988 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2024-04-13 |
| NCT02632890 |
Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries |
https://ClinicalTrials.gov/show/NCT02632890 |
Completed |
Bristol-Myers Squibb |
2017-04-28 |
| NCT02622503 |
A Study on Rheumatoid Arthritis Patients Treated With Rituximab |
https://ClinicalTrials.gov/show/NCT02622503 |
Completed |
Hoffmann-La Roche |
2008-08-31 |
| NCT02627924 |
Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab |
https://ClinicalTrials.gov/show/NCT02627924 |
Completed |
AbbVie |
2017-12-28 |
| NCT02616380 |
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan |
https://ClinicalTrials.gov/show/NCT02616380 |
Completed |
AbbVie |
2017-11-23 |
| NCT02608112 |
Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year |
https://ClinicalTrials.gov/show/NCT02608112 |
Completed |
Hoffmann-La Roche |
2018-07-26 |
| NCT02598466 |
Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa |
https://ClinicalTrials.gov/show/NCT02598466 |
Completed |
Bristol-Myers Squibb |
2016-01-31 |
| NCT02600468 |
Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg |
https://ClinicalTrials.gov/show/NCT02600468 |
Completed |
Bristol-Myers Squibb |
2015-12-31 |
| NCT02600455 |
Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL |
https://ClinicalTrials.gov/show/NCT02600455 |
Completed |
Bristol-Myers Squibb |
2016-06-30 |
| NCT02590562 |
An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients. |
https://ClinicalTrials.gov/show/NCT02590562 |
Completed |
Hoffmann-La Roche |
2014-08-31 |
| NCT02569736 |
Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation |
https://ClinicalTrials.gov/show/NCT02569736 |
Completed |
Association Aquitaine de Recherche Clinique en Rhumatologie |
2016-09-30 |
| NCT02565225 |
Mobile Medically Supervised Patient Management in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02565225 |
Completed |
Heinrich-Heine University, Duesseldorf |
2016-07-31 |
| NCT02556034 |
Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA. |
https://ClinicalTrials.gov/show/NCT02556034 |
Completed |
Centre de Rhumatologie de l’Est du Québec |
2018-11-16 |
| NCT02564770 |
A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia |
https://ClinicalTrials.gov/show/NCT02564770 |
Completed |
Hoffmann-La Roche |
2012-02-29 |
| NCT03389711 |
INCMNSZ - Rheumatoid Arthritis Cohort |
https://ClinicalTrials.gov/show/NCT03389711 |
Recruiting |
National Institute of Medical Sciences and Nutrition, Salvador Zubiran |
2024-02-04 |
| NCT02552940 |
An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice |
https://ClinicalTrials.gov/show/NCT02552940 |
Completed |
Hoffmann-La Roche |
2017-10-23 |
| NCT02544334 |
Oral Metagenomic Biomarkers in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02544334 |
Completed |
University of Florida |
2019-08-08 |
| NCT02534311 |
A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28) |
https://ClinicalTrials.gov/show/NCT02534311 |
Completed |
Hoffmann-La Roche |
2015-12-01 |
| NCT02507752 |
An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab |
https://ClinicalTrials.gov/show/NCT02507752 |
Completed |
Hoffmann-La Roche |
2012-06-30 |
| NCT03387423 |
Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03387423 |
Recruiting |
Pfizer |
2023-02-11 |
| NCT02500498 |
Safety Profile of Nulojix in Home Infusion Settings |
https://ClinicalTrials.gov/show/NCT02500498 |
Completed |
Bristol-Myers Squibb |
2015-06-30 |
| NCT02503046 |
Estimation of Pentraxin3 and PGingivalis Levels in Patients With Knee Joint and Gum Diseases |
https://ClinicalTrials.gov/show/NCT02503046 |
Completed |
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre |
2015-11-30 |
| NCT02486302 |
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. |
https://ClinicalTrials.gov/show/NCT02486302 |
Completed |
Pfizer |
2017-12-11 |
| NCT02485483 |
Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants |
https://ClinicalTrials.gov/show/NCT02485483 |
Completed |
Hoffmann-La Roche |
2015-07-31 |
| NCT02476084 |
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT02476084 |
Recruiting |
University of Oxford |
2020-10-31 |
| NCT02468986 |
Study of Venous Endothelial Cells in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02468986 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2019-08-31 |
| NCT02441920 |
Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02441920 |
Active, not recruiting |
University of Birmingham |
2012-11-30 |
| NCT02402894 |
Follow-up of Person-centered Care of Young Adults With Rheumatic Disease |
https://ClinicalTrials.gov/show/NCT02402894 |
Active, not recruiting |
Vastra Gotaland Region |
2020-12-31 |
| NCT02402686 |
Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT02402686 |
Completed |
Hoffmann-La Roche |
2018-12-17 |
| NCT02362074 |
Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02362074 |
Completed |
AbbVie |
2020-03-06 |
| NCT02350491 |
Study During Pregnancy of Expression of miRNAs in RA or SLE |
https://ClinicalTrials.gov/show/NCT02350491 |
Completed |
University Hospital, Strasbourg, France |
2018-10-14 |
| NCT02348086 |
Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02348086 |
Recruiting |
StemGenex |
2019-05-31 |
| NCT02346942 |
Factors Associated With Biologic DMARD Switching |
https://ClinicalTrials.gov/show/NCT02346942 |
Completed |
Bristol-Myers Squibb |
2015-12-31 |
| NCT02337244 |
Zimmer POLAR Persona - TKA (EMEA Study) |
https://ClinicalTrials.gov/show/NCT02337244 |
Recruiting |
Zimmer Biomet |
2026-11-30 |
| NCT02327650 |
To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations |
https://ClinicalTrials.gov/show/NCT02327650 |
Recruiting |
Shinshu University |
2016-04-30 |
| NCT02322801 |
Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker |
https://ClinicalTrials.gov/show/NCT02322801 |
Completed |
Hoffmann-La Roche |
2011-11-30 |
| NCT02313129 |
Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02313129 |
Completed |
Duke University |
2017-01-24 |
| NCT02296632 |
Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study |
https://ClinicalTrials.gov/show/NCT02296632 |
Completed |
Cedars-Sinai Medical Center |
2015-08-31 |
| NCT02288520 |
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02288520 |
Completed |
Nordic Pharma SAS |
2016-03-31 |
| NCT02281747 |
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries |
https://ClinicalTrials.gov/show/NCT02281747 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2022-05-31 |
| NCT02287610 |
A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02287610 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2015-10-31 |
| NCT02251860 |
Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice |
https://ClinicalTrials.gov/show/NCT02251860 |
Active, not recruiting |
Hoffmann-La Roche |
2020-07-31 |
| NCT02252744 |
Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02252744 |
Completed |
Western University of Health Sciences |
2014-06-30 |
| NCT02234960 |
Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT02234960 |
Completed |
Hoffmann-La Roche |
2016-07-31 |
| NCT02217137 |
Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients |
https://ClinicalTrials.gov/show/NCT02217137 |
Completed |
Singapore National Eye Centre |
2015-09-30 |
| NCT02202837 |
Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice |
https://ClinicalTrials.gov/show/NCT02202837 |
Completed |
Pfizer |
2017-04-24 |
| NCT02182739 |
Observational Study of Meloxicam in Any Labeled Indication |
https://ClinicalTrials.gov/show/NCT02182739 |
Completed |
Boehringer Ingelheim |
2001-12-31 |
| NCT02180516 |
Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome |
https://ClinicalTrials.gov/show/NCT02180516 |
Completed |
Boehringer Ingelheim |
2004-09-30 |
| NCT02184065 |
Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT02184065 |
Completed |
Boehringer Ingelheim |
2007-04-30 |
| NCT02184052 |
Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions |
https://ClinicalTrials.gov/show/NCT02184052 |
Completed |
Boehringer Ingelheim |
2005-03-31 |
| NCT02169544 |
Post-marketing Study Assessing the Long-Term Safety of Abatacept |
https://ClinicalTrials.gov/show/NCT02169544 |
Completed |
Bristol-Myers Squibb |
2017-02-28 |
| NCT02122406 |
Depression and Anxiety in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02122406 |
Completed |
University of Pavia |
2015-12-31 |
| NCT02109666 |
Long Term Experience With Abatacept in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT02109666 |
Completed |
Bristol-Myers Squibb |
2016-02-29 |
| NCT02111057 |
Perioperative Flare in RA: Characterization of Clinical and Biological Features |
https://ClinicalTrials.gov/show/NCT02111057 |
Completed |
Hospital for Special Surgery, New York |
2017-05-09 |
| NCT02101307 |
Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab) |
https://ClinicalTrials.gov/show/NCT02101307 |
Completed |
Hoffmann-La Roche |
2017-05-22 |
| NCT02094326 |
Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT02094326 |
Completed |
Fundación Andaluza de ReumatologÃa |
2014-10-31 |
| NCT02096120 |
Full Mouth Disinfection and Antibiotics for Periodontitis in High or Moderate Disease Activity Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02096120 |
Completed |
University Hospital Inselspital, Berne |
2017-08-01 |
| NCT02090556 |
Long-term Experience With Abatacept SC in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT02090556 |
Active, not recruiting |
Bristol-Myers Squibb |
2019-10-30 |
| NCT02064400 |
Pilot Study of Ultrasound in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02064400 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
2014-07-31 |
| NCT01313858 |
A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554) |
https://ClinicalTrials.gov/show/NCT01313858 |
Completed |
Merck Sharp & Dohme Corp. |
2015-09-30 |
| NCT01309282 |
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB) |
https://ClinicalTrials.gov/show/NCT01309282 |
Completed |
Hoffmann-La Roche |
2013-08-31 |
| NCT01294722 |
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Antiâ€Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea |
https://ClinicalTrials.gov/show/NCT01294722 |
Completed |
Janssen Korea, Ltd., Korea |
2012-08-31 |
| NCT01288287 |
Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients |
https://ClinicalTrials.gov/show/NCT01288287 |
Completed |
UCB Pharma |
2014-10-31 |
| NCT01283399 |
An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01283399 |
Completed |
Hoffmann-La Roche |
2014-04-30 |
| NCT01282372 |
Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab |
https://ClinicalTrials.gov/show/NCT01282372 |
Completed |
AbbVie |
2014-07-31 |
| NCT01273519 |
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab |
https://ClinicalTrials.gov/show/NCT01273519 |
Completed |
AbbVie |
2013-01-31 |
| NCT02051114 |
Discovering the Antecedents of Rheumatoid Arthritis Flare |
https://ClinicalTrials.gov/show/NCT02051114 |
Active, not recruiting |
Rockefeller University |
2021-02-28 |
| NCT02037737 |
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting |
https://ClinicalTrials.gov/show/NCT02037737 |
Completed |
Bristol-Myers Squibb |
2018-01-31 |
| NCT02012764 |
The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ? |
https://ClinicalTrials.gov/show/NCT02012764 |
Recruiting |
University of Leeds |
2020-01-31 |
| NCT01981473 |
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab |
https://ClinicalTrials.gov/show/NCT01981473 |
Completed |
Pfizer |
2014-12-31 |
| NCT01952509 |
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01952509 |
Completed |
Hoffmann-La Roche |
2016-09-30 |
| NCT01947465 |
Immunogenicity and Safety of Vaccinations in Immunocompromised Persons |
https://ClinicalTrials.gov/show/NCT01947465 |
Completed |
University of Zurich |
2015-12-31 |
| NCT01918267 |
U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497) |
https://ClinicalTrials.gov/show/NCT01918267 |
Completed |
Hoffmann-La Roche |
2017-10-10 |
| NCT01921478 |
A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01921478 |
Completed |
Hoffmann-La Roche |
2010-11-30 |
| NCT01877239 |
Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria |
https://ClinicalTrials.gov/show/NCT01877239 |
Completed |
Pfizer |
2016-01-07 |
| NCT01876329 |
Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01876329 |
Completed |
Keesler Air Force Base Medical Center |
2015-04-30 |
| NCT01870908 |
Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01870908 |
Completed |
Astellas Pharma Inc |
2015-03-31 |
| NCT01866150 |
A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01866150 |
Completed |
Hoffmann-La Roche |
2013-10-31 |
| NCT01850966 |
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01850966 |
Completed |
Eisai Inc. |
2014-04-13 |
| NCT01788098 |
Genetics and Mechanisms of Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01788098 |
Completed |
Slovak Academy of Sciences |
2012-06-30 |
| NCT01791205 |
ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01791205 |
Completed |
Hoffmann-La Roche |
2014-10-31 |
| NCT01783730 |
Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents |
https://ClinicalTrials.gov/show/NCT01783730 |
Completed |
AbbVie |
2015-09-30 |
| NCT01773681 |
Novel Imaging Markers for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01773681 |
Completed |
University of California, San Francisco |
2018-03-31 |
| NCT01770834 |
A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01770834 |
Completed |
Hoffmann-La Roche |
2017-01-25 |
| NCT01768858 |
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01768858 |
Completed |
AbbVie |
2017-08-13 |
| NCT01764321 |
Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors |
https://ClinicalTrials.gov/show/NCT01764321 |
Active, not recruiting |
UCB Pharma |
2020-08-31 |
| NCT01756235 |
Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01756235 |
Completed |
AbbVie |
2015-10-31 |
| NCT01752309 |
The Predictive Value of Ultrasound in Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01752309 |
Completed |
Erasmus Medical Center |
2013-07-31 |
| NCT01741688 |
An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01741688 |
Completed |
Hoffmann-La Roche |
2014-03-06 |
| NCT01736189 |
Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01736189 |
Completed |
AbbVie |
2018-04-16 |
| NCT01707186 |
Pictorial Representation of Illness and Self Measure |
https://ClinicalTrials.gov/show/NCT01707186 |
Completed |
University of Oxford |
2017-06-30 |
| NCT01706874 |
Effect Assessment of Periodontal Prophylaxis on Rheumatoid Arthritis Activity. |
https://ClinicalTrials.gov/show/NCT01706874 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-09-07 |
| NCT01706029 |
Pain Evaluation in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01706029 |
Completed |
University Hospital, Limoges |
2014-12-31 |
| NCT01705730 |
A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy |
https://ClinicalTrials.gov/show/NCT01705730 |
Completed |
Hoffmann-La Roche |
2014-12-12 |
| NCT01700543 |
Sidus(TM) Post Market Clinical Follow-up (PMCF) Study |
https://ClinicalTrials.gov/show/NCT01700543 |
Active, not recruiting |
Zimmer Biomet |
2020-07-31 |
| NCT01697202 |
Fatigue in Rheumatoid Arthritis - Longitudinal Study |
https://ClinicalTrials.gov/show/NCT01697202 |
Completed |
Göteborg University |
2012-12-31 |
| NCT01698515 |
Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases– Anti- TNF Substudy |
https://ClinicalTrials.gov/show/NCT01698515 |
Completed |
Johns Hopkins University |
2016-06-30 |
| NCT01692899 |
Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice |
https://ClinicalTrials.gov/show/NCT01692899 |
Completed |
Pfizer |
2011-09-30 |
| NCT01688193 |
Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male |
https://ClinicalTrials.gov/show/NCT01688193 |
Completed |
Hanmi Pharmaceutical Company Limited |
2012-12-31 |
| NCT01683604 |
Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia |
https://ClinicalTrials.gov/show/NCT01683604 |
Completed |
Hoffmann-La Roche |
2014-06-30 |
| NCT01685424 |
Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) |
https://ClinicalTrials.gov/show/NCT01685424 |
Completed |
Merck Sharp & Dohme Corp. |
2015-03-01 |
| NCT01677416 |
Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet |
https://ClinicalTrials.gov/show/NCT01677416 |
Completed |
Federal University of São Paulo |
2012-03-31 |
| NCT01671059 |
A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra) |
https://ClinicalTrials.gov/show/NCT01671059 |
Completed |
Hoffmann-La Roche |
2015-09-30 |
| NCT01672970 |
A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01672970 |
Completed |
Hoffmann-La Roche |
2015-01-31 |
| NCT01670045 |
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01670045 |
Completed |
Hoffmann-La Roche |
2014-06-30 |
| NCT01669902 |
An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01669902 |
Completed |
Hoffmann-La Roche |
2014-09-30 |
| NCT01667458 |
An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) |
https://ClinicalTrials.gov/show/NCT01667458 |
Completed |
Hoffmann-La Roche |
2012-12-31 |
| NCT01664117 |
An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy |
https://ClinicalTrials.gov/show/NCT01664117 |
Completed |
Hoffmann-La Roche |
2013-06-30 |
| NCT01664104 |
A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting |
https://ClinicalTrials.gov/show/NCT01664104 |
Completed |
Hoffmann-La Roche |
2013-12-31 |
| NCT01663506 |
A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) |
https://ClinicalTrials.gov/show/NCT01663506 |
Completed |
Hoffmann-La Roche |
2014-09-30 |
| NCT01649817 |
A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II) |
https://ClinicalTrials.gov/show/NCT01649817 |
Completed |
Hoffmann-La Roche |
2013-05-31 |
| NCT01646385 |
Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry |
https://ClinicalTrials.gov/show/NCT01646385 |
Completed |
Pfizer |
2012-08-31 |
| NCT01642706 |
Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments |
https://ClinicalTrials.gov/show/NCT01642706 |
Recruiting |
University Hospital, Montpellier |
2020-10-31 |
| NCT01640548 |
A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01640548 |
Completed |
Hoffmann-La Roche |
2013-06-30 |
| NCT01633346 |
Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01633346 |
Completed |
Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau |
2016-07-31 |
| NCT01623752 |
Prospective Evaluation of the Radiographic Efficacy of Enbrel |
https://ClinicalTrials.gov/show/NCT01623752 |
Completed |
Pfizer |
2018-03-31 |
| NCT01616641 |
Orofacial Evaluation in Women With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01616641 |
Completed |
Federal University of São Paulo |
NA |
| NCT01615419 |
An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01615419 |
Completed |
Hoffmann-La Roche |
2013-11-30 |
| NCT01617005 |
A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs) |
https://ClinicalTrials.gov/show/NCT01617005 |
Completed |
Hoffmann-La Roche |
2014-09-30 |
| NCT01613378 |
A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra) |
https://ClinicalTrials.gov/show/NCT01613378 |
Completed |
Hoffmann-La Roche |
2014-10-31 |
| NCT01613027 |
An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01613027 |
Completed |
Hoffmann-La Roche |
2015-09-30 |
| NCT01596348 |
Exercise Perceptions and Preferences Among Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01596348 |
Completed |
University of Lausanne |
2011-11-30 |
| NCT01592292 |
An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy |
https://ClinicalTrials.gov/show/NCT01592292 |
Completed |
Hoffmann-La Roche |
2014-12-31 |
| NCT01585064 |
Optimization of Treatment With Adalimumab (Humira) |
https://ClinicalTrials.gov/show/NCT01585064 |
Completed |
Lawson Health Research Institute |
2009-12-31 |
| NCT01583244 |
Korean Post-marketing Surveillance for Orencia® |
https://ClinicalTrials.gov/show/NCT01583244 |
Completed |
Bristol-Myers Squibb |
2016-02-29 |
| NCT01579006 |
Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01579006 |
Completed |
Hoffmann-La Roche |
2014-03-31 |
| NCT01577563 |
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). |
https://ClinicalTrials.gov/show/NCT01577563 |
Completed |
AstraZeneca |
2013-03-31 |
| NCT01565122 |
An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) |
https://ClinicalTrials.gov/show/NCT01565122 |
Completed |
Hoffmann-La Roche |
2014-05-31 |
| NCT01564901 |
An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids |
https://ClinicalTrials.gov/show/NCT01564901 |
Completed |
Hoffmann-La Roche |
2012-10-31 |
| NCT01562327 |
A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01562327 |
Completed |
Hoffmann-La Roche |
2014-03-31 |
| NCT01558089 |
Good EULAR Response In Patients With Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01558089 |
Completed |
Pfizer |
2015-05-31 |
| NCT01557348 |
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor |
https://ClinicalTrials.gov/show/NCT01557348 |
Completed |
Hoffmann-La Roche |
2012-03-31 |
| NCT01557322 |
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT01557322 |
Completed |
Pfizer |
2012-09-30 |
| NCT01543594 |
Italian Registry of Arthritis on Biologic Therapy |
https://ClinicalTrials.gov/show/NCT01543594 |
Recruiting |
Gruppo Italiano Studio Early Arthritis |
2020-05-31 |
| NCT01543503 |
An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01543503 |
Completed |
Hoffmann-La Roche |
2015-02-28 |
| NCT01526434 |
Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol |
https://ClinicalTrials.gov/show/NCT01526434 |
Completed |
UCB Pharma |
2014-03-31 |
| NCT01519375 |
Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) |
https://ClinicalTrials.gov/show/NCT01519375 |
Completed |
AstraZeneca |
2012-05-31 |
| NCT01521884 |
Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy |
https://ClinicalTrials.gov/show/NCT01521884 |
Completed |
Pfizer |
2014-02-28 |
| NCT01511926 |
Descriptive Study in Patients Treated With Vimovoâ„¢, Including Registration of the Physicians’ Prescribing Patterns |
https://ClinicalTrials.gov/show/NCT01511926 |
Completed |
AstraZeneca |
2014-03-31 |
| NCT01499732 |
Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects |
https://ClinicalTrials.gov/show/NCT01499732 |
Completed |
Orrin M Troum, M.D. and Medical Associates |
2012-11-30 |
| NCT01483326 |
An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct) |
https://ClinicalTrials.gov/show/NCT01483326 |
Completed |
Hoffmann-La Roche |
2017-06-19 |
| NCT01482507 |
Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01482507 |
Completed |
Optimus Clinical Research |
2014-12-31 |
| NCT01474291 |
An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01474291 |
Completed |
Hoffmann-La Roche |
2014-09-30 |
| NCT01480440 |
Outcomes Study of the TM Reverse Shoulder System Used in Primary or Revision Reverse Total Shoulder Arthroplasty |
https://ClinicalTrials.gov/show/NCT01480440 |
Active, not recruiting |
Zimmer Biomet |
2026-12-31 |
| NCT01462162 |
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01462162 |
Completed |
Hoffmann-La Roche |
2013-11-30 |
| NCT01438892 |
Impact Of RA Therapy Compliance On Patient-Reported Outcomes |
https://ClinicalTrials.gov/show/NCT01438892 |
Completed |
Pfizer |
2013-01-31 |
| NCT01432366 |
Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT01432366 |
Completed |
Pfizer |
2013-12-31 |
| NCT01402661 |
Corrona Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry |
https://ClinicalTrials.gov/show/NCT01402661 |
Enrolling by invitation |
Corrona, LLC. |
2100-12-31 |
| NCT01392001 |
An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) |
https://ClinicalTrials.gov/show/NCT01392001 |
Completed |
Hoffmann-La Roche |
2013-04-30 |
| NCT01394276 |
An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST) |
https://ClinicalTrials.gov/show/NCT01394276 |
Completed |
Hoffmann-La Roche |
2013-04-30 |
| NCT01388608 |
Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept |
https://ClinicalTrials.gov/show/NCT01388608 |
Completed |
University Hospital Muenster |
2013-01-31 |
| NCT01388309 |
An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs |
https://ClinicalTrials.gov/show/NCT01388309 |
Completed |
Hoffmann-La Roche |
2013-03-31 |
| NCT01387789 |
A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia |
https://ClinicalTrials.gov/show/NCT01387789 |
Completed |
AbbVie |
2013-03-31 |
| NCT01383421 |
Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP) |
https://ClinicalTrials.gov/show/NCT01383421 |
Completed |
AbbVie |
2016-04-30 |
| NCT01384461 |
An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE) |
https://ClinicalTrials.gov/show/NCT01384461 |
Completed |
Hoffmann-La Roche |
2013-05-31 |
| NCT01375478 |
An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01375478 |
Completed |
Hoffmann-La Roche |
2012-04-30 |
| NCT01362062 |
Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy |
https://ClinicalTrials.gov/show/NCT01362062 |
Completed |
Hoffmann-La Roche |
2015-01-01 |
| NCT01357018 |
Quality of Life in Chronic Arthritis |
https://ClinicalTrials.gov/show/NCT01357018 |
Completed |
Far Eastern Memorial Hospital |
2012-12-31 |
| NCT01345071 |
Preconceptional Counselling in Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01345071 |
Recruiting |
Erasmus Medical Center |
2021-06-30 |
| NCT01346501 |
Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069 |
https://ClinicalTrials.gov/show/NCT01346501 |
Completed |
AbbVie |
2014-11-30 |
| NCT01346488 |
Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment) |
https://ClinicalTrials.gov/show/NCT01346488 |
Completed |
AbbVie |
2016-01-31 |
| NCT01339481 |
A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept |
https://ClinicalTrials.gov/show/NCT01339481 |
Completed |
Astellas Pharma Inc |
2011-10-31 |
| NCT01338545 |
An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE) |
https://ClinicalTrials.gov/show/NCT01338545 |
Completed |
Hoffmann-La Roche |
2012-09-30 |
| NCT01337388 |
An Observational Study of RoActemra/Actemra (Tocilizumab) in Smoking Versus Non-Smoking Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01337388 |
Completed |
Hoffmann-La Roche |
2013-10-31 |
| NCT04416997 |
Rheumatoid Arthritis Hematological Indices |
https://ClinicalTrials.gov/show/NCT04416997 |
Recruiting |
Assiut University |
2022-10-29 |
| NCT04407559 |
COVID-SErology in Rheumatoid Arthritis (COVID-19) |
https://ClinicalTrials.gov/show/NCT04407559 |
Active, not recruiting |
University Hospital, Montpellier |
2020-09-01 |
| NCT04413448 |
Performance of CT Parameters Compared to Bone Mineral Density to Detect Bone Fragility in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04413448 |
Completed |
Central Hospital, Nancy, France |
2020-01-01 |
| NCT04393233 |
Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation |
https://ClinicalTrials.gov/show/NCT04393233 |
Recruiting |
University Hospital, Brest |
2020-05-23 |
| NCT04384068 |
The Safety and Effectiveness of Tocilizumab in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04384068 |
Recruiting |
Peking Union Medical College Hospital |
2021-01-31 |
| NCT04389320 |
Antimalarial and Covid 19 in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04389320 |
Completed |
Assiut University |
2020-05-01 |
| NCT04351399 |
Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04351399 |
Completed |
University Hospital, Lille |
2020-05-04 |
| NCT04343378 |
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04343378 |
Active, not recruiting |
University Hospital, Rouen |
2023-04-30 |
| NCT04340115 |
Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets |
https://ClinicalTrials.gov/show/NCT04340115 |
Recruiting |
AbbVie |
2024-04-26 |
| NCT04297475 |
The Clinical Feasibilityof a Multi-modal Photoacoustic/Ultrasonic Imaging System in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04297475 |
Recruiting |
Peking Union Medical College Hospital |
2020-12-31 |
| NCT04281602 |
Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy |
https://ClinicalTrials.gov/show/NCT04281602 |
Recruiting |
University Hospital, Caen |
2023-01-02 |
| NCT04267614 |
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients. |
https://ClinicalTrials.gov/show/NCT04267614 |
Completed |
Pfizer |
2018-12-01 |
| NCT04267536 |
An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04267536 |
Recruiting |
AbbVie |
2023-03-31 |
| NCT04267380 |
A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day |
https://ClinicalTrials.gov/show/NCT04267380 |
Completed |
Pfizer |
2019-08-31 |
| NCT04227535 |
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2 |
https://ClinicalTrials.gov/show/NCT04227535 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2027-03-01 |
| NCT04210817 |
A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04210817 |
Recruiting |
ProgenaBiome |
2023-03-31 |
| NCT04201535 |
Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT04201535 |
Recruiting |
Istituto Ortopedico Galeazzi |
2020-09-30 |
| NCT04188249 |
Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04188249 |
Recruiting |
Peking Union Medical College Hospital |
2021-03-01 |
| NCT04191395 |
Evolution and Treatments of Chronic Inflammatory Systemic Diseases |
https://ClinicalTrials.gov/show/NCT04191395 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2029-12-31 |
| NCT04175886 |
Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project |
https://ClinicalTrials.gov/show/NCT04175886 |
Recruiting |
University Hospital, Lille |
2023-03-31 |
| NCT04139954 |
Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs |
https://ClinicalTrials.gov/show/NCT04139954 |
Recruiting |
Turkish League Against Rheumatism |
2020-03-01 |
| NCT04134169 |
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202) |
https://ClinicalTrials.gov/show/NCT04134169 |
Recruiting |
Kang Stem Biotech Co., Ltd. |
2025-08-11 |
| NCT04089514 |
A Real-world Study of Imraldi® Use |
https://ClinicalTrials.gov/show/NCT04089514 |
Recruiting |
Biogen |
2021-06-30 |
| NCT04056234 |
Study of the Articular Microbiota in Rheumatoid Arthritis. |
https://ClinicalTrials.gov/show/NCT04056234 |
Completed |
University Hospital, Bordeaux |
2013-02-22 |
| NCT04047121 |
A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT04047121 |
Completed |
Pfizer |
2019-10-21 |
| NCT04022525 |
Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic Approaches |
https://ClinicalTrials.gov/show/NCT04022525 |
Active, not recruiting |
Assiut University |
2019-08-31 |
| NCT04018001 |
Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR) |
https://ClinicalTrials.gov/show/NCT04018001 |
Completed |
Pfizer |
2019-04-25 |
| NCT03999528 |
14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03999528 |
Completed |
Al-Azhar University |
2019-08-01 |
| NCT03981900 |
IDentification of Factors Predictive of Tofacitinib’s Survival in Patient With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03981900 |
Recruiting |
Pfizer |
2023-01-31 |
| NCT03977415 |
Interstitial Lung Disease in Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03977415 |
Recruiting |
National Jewish Health |
2020-02-01 |
| NCT03980639 |
Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase |
https://ClinicalTrials.gov/show/NCT03980639 |
Recruiting |
University Hospital, Toulouse |
2019-06-28 |
| NCT03975790 |
Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX |
https://ClinicalTrials.gov/show/NCT03975790 |
Completed |
Pfizer |
2018-10-02 |
| NCT03971253 |
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03971253 |
Recruiting |
Astellas Pharma Inc |
2025-12-31 |
| NCT03972098 |
Uromodulin in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03972098 |
Completed |
Istanbul Saglik Bilimleri University |
2018-05-01 |
| NCT03964649 |
Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics |
https://ClinicalTrials.gov/show/NCT03964649 |
Completed |
Pfizer |
2020-04-06 |
| NCT03953378 |
CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT03953378 |
Completed |
Hospices Civils de Lyon |
2018-12-31 |
| NCT03960515 |
Cardiovascular Profiles in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03960515 |
Completed |
Centro Hospitalar do Porto |
2019-04-05 |
| NCT03952897 |
Quality of Life Related to Health in Spa Users |
https://ClinicalTrials.gov/show/NCT03952897 |
Active, not recruiting |
University of Castilla-La Mancha |
2019-03-01 |
| NCT03937271 |
Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03937271 |
Active, not recruiting |
Taipei Veterans General Hospital, Taiwan |
2019-05-31 |
| NCT03908086 |
Bloodstream Infections in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03908086 |
Completed |
Rigshospitalet, Denmark |
2017-12-31 |
| NCT03885037 |
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg “Pfizer” Drug Use Investigation (Rheumatoid Arthritis) |
https://ClinicalTrials.gov/show/NCT03885037 |
Recruiting |
Pfizer |
2025-03-12 |
| NCT03841279 |
Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03841279 |
Recruiting |
Mayo Clinic |
2021-07-31 |
| NCT03810144 |
Impact of Guided Care With the Vectra DA Multi-biomarker Disease Activity (MBDA) Blood Test |
https://ClinicalTrials.gov/show/NCT03810144 |
Recruiting |
Myriad Genetic Laboratories, Inc. |
2021-03-31 |
| NCT03802890 |
Microbial Dysbiosis in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03802890 |
Enrolling by invitation |
Quadram Institute Bioscience |
2021-04-30 |
| NCT03785197 |
Effects of a Clinical Dietary Intervention During Inpatient Treatment |
https://ClinicalTrials.gov/show/NCT03785197 |
Recruiting |
Charite University, Berlin, Germany |
2020-03-01 |
| NCT03776682 |
Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study |
https://ClinicalTrials.gov/show/NCT03776682 |
Recruiting |
Mayo Clinic |
2020-06-18 |
| NCT03775824 |
Faecal Analyses in Rheumatoid Arthritis Therapy |
https://ClinicalTrials.gov/show/NCT03775824 |
Completed |
Region Skane |
2018-11-01 |
| NCT03770884 |
Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs) |
https://ClinicalTrials.gov/show/NCT03770884 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2019-07-31 |
| NCT03754855 |
Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT03754855 |
Completed |
University Hospital, Bordeaux |
2019-07-10 |
| NCT03743181 |
Impact of Clinical Pharmacy Services Provided for Patients With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03743181 |
Completed |
Ain Shams University |
2019-10-10 |
| NCT03719469 |
Circulating microRNAs as Novel Prognosis Biomarkers for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03719469 |
Completed |
King Saud University |
2015-01-20 |
| NCT03729349 |
Golimumab for Adherence in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03729349 |
Recruiting |
Janssen Inc. |
2020-12-01 |
| NCT03703817 |
Rheumatoid Arthritis Satisfaction Outcome Research |
https://ClinicalTrials.gov/show/NCT03703817 |
Completed |
Pfizer |
2020-03-12 |
| NCT03696173 |
Safety Study of Abatacept in Rheumatoid Arthritis Participants |
https://ClinicalTrials.gov/show/NCT03696173 |
Completed |
Bristol-Myers Squibb |
2018-06-29 |
| NCT03670667 |
A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents |
https://ClinicalTrials.gov/show/NCT03670667 |
Active, not recruiting |
Bristol-Myers Squibb |
2019-03-29 |
| NCT03666091 |
Study and Monitoring of Early Undifferentiated Arthritis |
https://ClinicalTrials.gov/show/NCT03666091 |
Active, not recruiting |
Societe Francaise de Rhumatologie |
2005-04-19 |
| NCT03662919 |
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study |
https://ClinicalTrials.gov/show/NCT03662919 |
Recruiting |
Biogen |
2022-06-30 |
| NCT03663829 |
Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia |
https://ClinicalTrials.gov/show/NCT03663829 |
Active, not recruiting |
Bristol-Myers Squibb |
2019-01-31 |
| NCT03626116 |
Patient Satisfaction After Silicone Metacarpophalangeal Arthroplasty |
https://ClinicalTrials.gov/show/NCT03626116 |
Completed |
Schulthess Klinik |
2018-12-19 |
| NCT03631225 |
The Effect of Guided Care With Vectra DA Compared to Treatment as Usual in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03631225 |
Recruiting |
Myriad Genetic Laboratories, Inc. |
2021-10-01 |
| NCT03615729 |
RORC Genetic Polymorphism of Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03615729 |
Completed |
Assiut University |
2018-03-30 |
| NCT03616158 |
Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time |
https://ClinicalTrials.gov/show/NCT03616158 |
Recruiting |
National Jewish Health |
2023-05-10 |
| NCT03550833 |
Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Multifactorial and Integrative Psychological Model |
https://ClinicalTrials.gov/show/NCT03550833 |
Completed |
University Hospital, Bordeaux |
2019-07-04 |
| NCT03555240 |
Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03555240 |
Completed |
Istituto Ortopedico Rizzoli |
2018-09-28 |
| NCT03543488 |
Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease |
https://ClinicalTrials.gov/show/NCT03543488 |
Completed |
Federal University of Rio Grande do Sul |
2013-11-20 |
| NCT03535519 |
Rheumatoid Arthritis Response to Methotrexate |
https://ClinicalTrials.gov/show/NCT03535519 |
Recruiting |
Hospital General Universitario Gregorio Marañon |
2020-08-31 |
| NCT03540667 |
Study of Hip and Knee Arthroplasty in South Africa |
https://ClinicalTrials.gov/show/NCT03540667 |
Recruiting |
University of Cape Town |
2020-11-30 |
| NCT03457792 |
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03457792 |
Recruiting |
Bristol-Myers Squibb |
2021-03-12 |
| NCT03452735 |
Fertility Study of Women With Chronic Inflammatory Rheumatism |
https://ClinicalTrials.gov/show/NCT03452735 |
Recruiting |
University Hospital, Toulouse |
2019-07-31 |
| NCT03444623 |
Survivin as Predictive Biomarker for RA |
https://ClinicalTrials.gov/show/NCT03444623 |
Recruiting |
Vastra Gotaland Region |
2020-06-30 |
| NCT03440892 |
Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT03440892 |
Recruiting |
Vastra Gotaland Region |
2022-01-31 |
| NCT03429426 |
Progression of Bone Erosions in Rheumatoid Arthritis Assessed by HR-pQCT and Conventional X-ray |
https://ClinicalTrials.gov/show/NCT03429426 |
Enrolling by invitation |
Aarhus University Hospital |
2022-02-01 |
| NCT03423953 |
Comprehensive Nano - PMCF Study |
https://ClinicalTrials.gov/show/NCT03423953 |
Recruiting |
Zimmer Biomet |
2030-07-31 |
| NCT03416543 |
Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03416543 |
Recruiting |
University Hospital, Tours |
2020-12-31 |
| NCT03411057 |
Mindfulness Based Stress Reduction in Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT03411057 |
Enrolling by invitation |
Johns Hopkins University |
2021-01-18 |
| NCT01228812 |
Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls |
https://ClinicalTrials.gov/show/NCT01228812 |
Completed |
University of Lausanne |
2010-09-30 |
| NCT01211678 |
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients |
https://ClinicalTrials.gov/show/NCT01211678 |
Completed |
Biogen |
2013-07-31 |
| NCT01187563 |
A Study of Tocilizumab in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01187563 |
Completed |
Regeneron Pharmaceuticals |
2010-12-31 |
| NCT01185522 |
An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS) |
https://ClinicalTrials.gov/show/NCT01185522 |
Completed |
Hoffmann-La Roche |
2011-05-31 |
| NCT01180361 |
Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance |
https://ClinicalTrials.gov/show/NCT01180361 |
Recruiting |
Winthrop University Hospital |
2020-12-31 |
| NCT01176682 |
Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder |
https://ClinicalTrials.gov/show/NCT01176682 |
Completed |
AstraZeneca |
2011-08-31 |
| NCT01166620 |
Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics |
https://ClinicalTrials.gov/show/NCT01166620 |
Completed |
Bristol-Myers Squibb |
2011-09-30 |
| NCT01163916 |
Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care |
https://ClinicalTrials.gov/show/NCT01163916 |
Completed |
Abbott |
2011-11-30 |
| NCT01163318 |
Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01163318 |
Completed |
AbbVie |
2014-05-31 |
| NCT01163292 |
Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467)) |
https://ClinicalTrials.gov/show/NCT01163292 |
Completed |
AbbVie |
2012-10-31 |
| NCT01156155 |
Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01156155 |
Completed |
University of Nebraska |
2012-07-31 |
| NCT01144598 |
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey |
https://ClinicalTrials.gov/show/NCT01144598 |
Completed |
Abbott |
2011-08-31 |
| NCT01141413 |
Dose Escalation With Remicade® and Orencia® |
https://ClinicalTrials.gov/show/NCT01141413 |
Completed |
Bristol-Myers Squibb |
2010-08-31 |
| NCT01136707 |
Predictors of Adherence to Orencia |
https://ClinicalTrials.gov/show/NCT01136707 |
Completed |
Bristol-Myers Squibb |
2010-07-31 |
| NCT01137851 |
Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01137851 |
Completed |
Bristol-Myers Squibb |
2010-09-30 |
| NCT01137838 |
Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents |
https://ClinicalTrials.gov/show/NCT01137838 |
Completed |
Bristol-Myers Squibb |
2010-10-31 |
| NCT01136694 |
Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs) |
https://ClinicalTrials.gov/show/NCT01136694 |
Completed |
Bristol-Myers Squibb |
2011-04-30 |
| NCT01117480 |
Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA |
https://ClinicalTrials.gov/show/NCT01117480 |
Completed |
AbbVie |
2014-12-31 |
| NCT01102829 |
Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis Design |
https://ClinicalTrials.gov/show/NCT01102829 |
Completed |
Leiden University Medical Center |
2010-04-30 |
| NCT01105715 |
Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01105715 |
Completed |
University of Arkansas |
2013-06-30 |
| NCT01098201 |
Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT01098201 |
Completed |
University of Rochester |
2014-07-31 |
| NCT01095393 |
National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) |
https://ClinicalTrials.gov/show/NCT01095393 |
Enrolling by invitation |
UCB Pharma |
2016-12-13 |
| NCT01088360 |
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) |
https://ClinicalTrials.gov/show/NCT01088360 |
Active, not recruiting |
Bristol-Myers Squibb |
2029-06-30 |
| NCT01088321 |
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A) |
https://ClinicalTrials.gov/show/NCT01088321 |
Completed |
Bristol-Myers Squibb |
2016-11-30 |
| NCT01087125 |
Abatacept Pregnancy Exposure Registry |
https://ClinicalTrials.gov/show/NCT01087125 |
Recruiting |
Bristol-Myers Squibb |
2019-12-31 |
| NCT01083693 |
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs |
https://ClinicalTrials.gov/show/NCT01083693 |
Completed |
Abbott |
2010-06-30 |
| NCT01086059 |
OTIS Autoimmune Diseases in Pregnancy Project |
https://ClinicalTrials.gov/show/NCT01086059 |
Active, not recruiting |
University of California, San Diego |
2016-08-31 |
| NCT01086033 |
A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece |
https://ClinicalTrials.gov/show/NCT01086033 |
Completed |
AbbVie |
2012-07-31 |
| NCT01081717 |
Golimumab Safety and Surveillance Program Using the Ingenix NHI Database |
https://ClinicalTrials.gov/show/NCT01081717 |
Completed |
Janssen Biotech, Inc. |
2015-05-31 |
| NCT01078597 |
A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA |
https://ClinicalTrials.gov/show/NCT01078597 |
Completed |
AbbVie |
2013-07-31 |
| NCT01078571 |
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01078571 |
Completed |
Abbott |
2010-05-31 |
| NCT01077258 |
Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01077258 |
Completed |
AbbVie |
2013-02-28 |
| NCT01078558 |
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) |
https://ClinicalTrials.gov/show/NCT01078558 |
Completed |
AbbVie |
2018-01-11 |
| NCT01076959 |
Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01076959 |
Completed |
Abbott |
2011-06-30 |
| NCT01076205 |
Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01076205 |
Completed |
AbbVie |
2017-09-14 |
| NCT01078402 |
EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries |
https://ClinicalTrials.gov/show/NCT01078402 |
Completed |
AbbVie |
2011-11-30 |
| NCT01075711 |
Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) |
https://ClinicalTrials.gov/show/NCT01075711 |
Completed |
Merck KGaA, Darmstadt, Germany |
2010-09-30 |
| NCT01078155 |
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01078155 |
Completed |
AbbVie |
2014-05-31 |
| NCT01075477 |
An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab) |
https://ClinicalTrials.gov/show/NCT01075477 |
Completed |
Hoffmann-La Roche |
2011-12-31 |
| NCT01078116 |
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT01078116 |
Completed |
Abbott |
2010-06-30 |
| NCT01078090 |
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01078090 |
Completed |
AbbVie |
2013-03-31 |
| NCT01071798 |
An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01071798 |
Completed |
Hoffmann-La Roche |
2014-10-31 |
| NCT01069419 |
Observation of Treatment With Certolizumab Pegol in Daily Practice |
https://ClinicalTrials.gov/show/NCT01069419 |
Completed |
UCB Pharma |
2014-09-30 |
| NCT01070121 |
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository |
https://ClinicalTrials.gov/show/NCT01070121 |
Completed |
University of Alabama at Birmingham |
2012-08-31 |
| NCT01060098 |
T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade |
https://ClinicalTrials.gov/show/NCT01060098 |
Completed |
Imperial College London |
2012-12-31 |
| NCT01044823 |
Use of Thermal and 3D Imaging to Quantify Arthritis |
https://ClinicalTrials.gov/show/NCT01044823 |
Completed |
University of Pittsburgh |
2011-03-31 |
| NCT01038349 |
Applications for Methotrexate Optimization in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01038349 |
Completed |
Cypress Bioscience, Inc. |
2009-12-31 |
| NCT01029613 |
Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers |
https://ClinicalTrials.gov/show/NCT01029613 |
Completed |
Glostrup University Hospital, Copenhagen |
2013-07-31 |
| NCT01001182 |
Health Outcomes in Rheumatoid Arthritis in Greece |
https://ClinicalTrials.gov/show/NCT01001182 |
Completed |
Pfizer |
2012-06-30 |
| NCT00989677 |
Rheumatoid Arthritis Disease Activity Monitor |
https://ClinicalTrials.gov/show/NCT00989677 |
Completed |
Maxima Medical Center |
2009-06-30 |
| NCT00990730 |
Atherosclerosis in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00990730 |
Completed |
University of California, San Francisco |
2011-06-30 |
| NCT00944320 |
Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan |
https://ClinicalTrials.gov/show/NCT00944320 |
Completed |
National Chung Hsing University |
2007-02-28 |
| NCT00944255 |
Pharmacogenetics of Antifolate Drugs in Autoimmune Diseases in Taiwan |
https://ClinicalTrials.gov/show/NCT00944255 |
Completed |
National Chung Hsing University |
2008-02-29 |
| NCT00938444 |
Evaluation of the BRADA and ABILHAND Questionnaires |
https://ClinicalTrials.gov/show/NCT00938444 |
Completed |
University Hospital, Ghent |
2010-12-31 |
| NCT00929357 |
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment |
https://ClinicalTrials.gov/show/NCT00929357 |
Completed |
Pfizer |
2010-06-30 |
| NCT00902005 |
Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment |
https://ClinicalTrials.gov/show/NCT00902005 |
Completed |
Revmatismesykehuset AS |
2011-06-30 |
| NCT00895050 |
Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients |
https://ClinicalTrials.gov/show/NCT00895050 |
Completed |
Pfizer |
2011-01-31 |
| NCT00888576 |
Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan |
https://ClinicalTrials.gov/show/NCT00888576 |
Completed |
Pfizer |
2011-12-31 |
| NCT00881881 |
Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain |
https://ClinicalTrials.gov/show/NCT00881881 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-04-30 |
| NCT00858169 |
Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler Ultrasonography |
https://ClinicalTrials.gov/show/NCT00858169 |
Completed |
Taichung Veterans General Hospital |
2010-03-31 |
| NCT00854321 |
Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital |
https://ClinicalTrials.gov/show/NCT00854321 |
Completed |
Kuopio University Hospital |
2008-07-31 |
| NCT00847236 |
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica |
https://ClinicalTrials.gov/show/NCT00847236 |
Completed |
Lahey Clinic |
2013-08-31 |
| NCT00840957 |
Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00840957 |
Completed |
University Hospital, Tours |
2009-11-30 |
| NCT00832910 |
Assessment of Body Image in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00832910 |
Completed |
Federal University of São Paulo |
NA |
| NCT03100734 |
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel |
https://ClinicalTrials.gov/show/NCT03100734 |
Completed |
Biogen |
2018-11-30 |
| NCT02968745 |
Occupational Performance Problems in Individuals With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02968745 |
Completed |
Federal University of Minas Gerais |
2009-08-31 |
| NCT02008266 |
Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02008266 |
Completed |
Hoffmann-La Roche |
2012-12-31 |
| NCT01111357 |
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01111357 |
Completed |
University Hospital Center of Martinique |
2010-08-31 |
| NCT00815425 |
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry) |
https://ClinicalTrials.gov/show/NCT00815425 |
Completed |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
2011-12-31 |
| NCT01932372 |
Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01932372 |
Active, not recruiting |
Pfizer |
2020-12-15 |
| NCT01417455 |
Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01417455 |
Completed |
Instituto de Medicina Molecular João Lobo Antunes |
2015-01-31 |
| NCT03599986 |
Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03599986 |
Completed |
Eva Pharma |
2018-10-13 |
| NCT04036669 |
Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04036669 |
Completed |
King Saud University |
2015-04-30 |
| NCT01834807 |
A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01834807 |
Completed |
Hoffmann-La Roche |
2013-08-31 |
| NCT01641952 |
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent |
https://ClinicalTrials.gov/show/NCT01641952 |
Completed |
Hoffmann-La Roche |
2015-01-31 |
| NCT01555879 |
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry |
https://ClinicalTrials.gov/show/NCT01555879 |
Completed |
Arthritis Northwest PLLC |
2016-11-30 |
| NCT01476956 |
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography |
https://ClinicalTrials.gov/show/NCT01476956 |
Active, not recruiting |
Canadian Research & Education in Arthritis |
2018-12-31 |
| NCT01476865 |
Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT01476865 |
Completed |
Federal University of São Paulo |
2011-06-30 |
| NCT00794118 |
Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose) |
https://ClinicalTrials.gov/show/NCT00794118 |
Completed |
Pfizer |
2011-04-30 |
| NCT03675516 |
Comorbidities and Outcomes in Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03675516 |
Completed |
Momentum Data |
2019-01-01 |
| NCT00793403 |
Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study |
https://ClinicalTrials.gov/show/NCT00793403 |
Completed |
Pfizer |
2010-06-30 |
| NCT00786227 |
Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA) |
https://ClinicalTrials.gov/show/NCT00786227 |
Completed |
Stanford University |
2009-07-31 |
| NCT00781989 |
Ultrasonography as a Biomarker in Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00781989 |
Completed |
Imperial College London |
2011-04-30 |
| NCT00781469 |
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood |
https://ClinicalTrials.gov/show/NCT00781469 |
Completed |
Imperial College London |
2010-10-31 |
| NCT00760669 |
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants |
https://ClinicalTrials.gov/show/NCT00760669 |
Completed |
Janssen Korea, Ltd., Korea |
2011-04-30 |
| NCT00751387 |
Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia |
https://ClinicalTrials.gov/show/NCT00751387 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-09-30 |
| NCT00748254 |
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis |
https://ClinicalTrials.gov/show/NCT00748254 |
Active, not recruiting |
University of Michigan |
2021-01-31 |
| NCT00748826 |
Remicade Safety Line (Study P03236)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00748826 |
Completed |
Merck Sharp & Dohme Corp. |
2010-12-31 |
| NCT00741104 |
A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) |
https://ClinicalTrials.gov/show/NCT00741104 |
Completed |
Merck Sharp & Dohme Corp. |
2008-06-30 |
| NCT00741793 |
Biologic Treatment Registry Across Canada |
https://ClinicalTrials.gov/show/NCT00741793 |
Completed |
Janssen Inc. |
2018-06-27 |
| NCT00725621 |
Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00725621 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT00727298 |
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) |
https://ClinicalTrials.gov/show/NCT00727298 |
Completed |
Merck Sharp & Dohme Corp. |
2011-08-31 |
| NCT00724243 |
Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00724243 |
Completed |
Merck Sharp & Dohme Corp. |
2008-10-31 |
| NCT00723905 |
Remicade Infusion Management Program |
https://ClinicalTrials.gov/show/NCT00723905 |
Completed |
Janssen Inc. |
2012-10-31 |
| NCT00721994 |
Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects |
https://ClinicalTrials.gov/show/NCT00721994 |
Completed |
Corin |
2017-06-30 |
| NCT00705289 |
A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) |
https://ClinicalTrials.gov/show/NCT00705289 |
Completed |
Merck Sharp & Dohme Corp. |
2008-09-30 |
| NCT00661284 |
A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) |
https://ClinicalTrials.gov/show/NCT00661284 |
Completed |
Chugai Pharmaceutical |
2009-03-31 |
| NCT00658827 |
Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis |
https://ClinicalTrials.gov/show/NCT00658827 |
Completed |
Janssen Biotech, Inc. |
2016-09-30 |
| NCT00619177 |
Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life |
https://ClinicalTrials.gov/show/NCT00619177 |
Completed |
Boehringer Ingelheim |
2008-05-31 |
| NCT00612885 |
Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study |
https://ClinicalTrials.gov/show/NCT00612885 |
Completed |
Boehringer Ingelheim |
2005-08-31 |
| NCT00594451 |
Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity |
https://ClinicalTrials.gov/show/NCT00594451 |
Completed |
University of Nebraska |
2010-04-30 |
| NCT00595894 |
Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans |
https://ClinicalTrials.gov/show/NCT00595894 |
Completed |
University of Nebraska |
2012-07-31 |
| NCT00522002 |
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study |
https://ClinicalTrials.gov/show/NCT00522002 |
Completed |
George Washington University |
2010-06-30 |
| NCT00513591 |
Duke Autoimmunity in Pregnancy Registry |
https://ClinicalTrials.gov/show/NCT00513591 |
Completed |
Duke University |
2018-11-19 |
| NCT00503503 |
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan |
https://ClinicalTrials.gov/show/NCT00503503 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-10-31 |
| NCT00503139 |
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan |
https://ClinicalTrials.gov/show/NCT00503139 |
Completed |
Pfizer |
2013-04-30 |
| NCT00488475 |
Observational Trial With Enbrel |
https://ClinicalTrials.gov/show/NCT00488475 |
Completed |
Pfizer |
2013-04-30 |
| NCT00484809 |
Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children |
https://ClinicalTrials.gov/show/NCT00484809 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00471874 |
Study Evaluating Health Related Utility in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00471874 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00440817 |
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn’s Disease. |
https://ClinicalTrials.gov/show/NCT00440817 |
Completed |
Centocor Ortho Biotech Services, L.L.C. |
2006-08-31 |
| NCT00443443 |
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) |
https://ClinicalTrials.gov/show/NCT00443443 |
Completed |
Genentech, Inc. |
2013-09-30 |
| NCT00439894 |
Ancillary Study to Protocol 20060104 |
https://ClinicalTrials.gov/show/NCT00439894 |
Completed |
Amgen |
2007-08-31 |
| NCT00414661 |
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550 |
https://ClinicalTrials.gov/show/NCT00414661 |
Completed |
Pfizer |
2012-02-29 |
| NCT00412399 |
Job Adaptation in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00412399 |
Completed |
Hospital for Special Surgery, New York |
NA |
| NCT00346411 |
Health Outcomes in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00346411 |
Completed |
Johns Hopkins University |
2011-12-12 |
| NCT00330889 |
Effects Of Prednisolone On Rheumatoid Arthritis Patients |
https://ClinicalTrials.gov/show/NCT00330889 |
Completed |
GlaxoSmithKline |
2006-12-31 |
| NCT00267852 |
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00267852 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2010-07-31 |
| NCT00261976 |
A Long-term Safety Study of Infliximab (Remicade) |
https://ClinicalTrials.gov/show/NCT00261976 |
Completed |
Centocor, Inc. |
2012-03-31 |
| NCT00242853 |
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00242853 |
Completed |
GlaxoSmithKline |
NA |
| NCT00245934 |
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00245934 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00240136 |
Long-term Observation of Patients With Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00240136 |
Active, not recruiting |
University of California, Los Angeles |
2022-12-31 |
| NCT00234884 |
Post-marketing Observational Study in Subjects With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00234884 |
Completed |
Abbott |
2010-07-31 |
| NCT00213564 |
Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00213564 |
Completed |
University Hospital, Rouen |
2004-05-31 |
| NCT00213538 |
Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00213538 |
Completed |
University Hospital, Rouen |
2016-12-31 |
| NCT00195403 |
A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA |
https://ClinicalTrials.gov/show/NCT00195403 |
Completed |
Pfizer |
2008-02-29 |
| NCT00195377 |
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain |
https://ClinicalTrials.gov/show/NCT00195377 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2006-04-30 |
| NCT00195364 |
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain |
https://ClinicalTrials.gov/show/NCT00195364 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-10-31 |
| NCT00195338 |
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg |
https://ClinicalTrials.gov/show/NCT00195338 |
Completed |
Pfizer |
2010-12-31 |
| NCT00121056 |
REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations |
https://ClinicalTrials.gov/show/NCT00121056 |
Completed |
Amgen |
NA |
| NCT00116727 |
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy |
https://ClinicalTrials.gov/show/NCT00116727 |
Completed |
Amgen |
2008-06-30 |
| NCT00116714 |
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy |
https://ClinicalTrials.gov/show/NCT00116714 |
Completed |
Amgen |
2007-12-31 |
| NCT00078793 |
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00078793 |
Completed |
Amgen |
2008-01-31 |
| NCT00074555 |
Registry for African Americans With Early Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00074555 |
Completed |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
2011-12-31 |
| NCT00071149 |
Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00071149 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00069472 |
Genetic Registry for Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00069472 |
Completed |
Northwell Health |
2015-08-31 |
| NCT00069342 |
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT00069342 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00056602 |
Clinically Important Changes in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00056602 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-03-01 |
| NCT00001679 |
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients |
https://ClinicalTrials.gov/show/NCT00001679 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001376 |
Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status |
https://ClinicalTrials.gov/show/NCT00001376 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001375 |
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis |
https://ClinicalTrials.gov/show/NCT00001375 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001291 |
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions |
https://ClinicalTrials.gov/show/NCT00001291 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037336 |
Atherosclerosis in Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00037336 |
Completed |
Vanderbilt University |
2007-07-31 |
| NCT00796809 |
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis |
https://ClinicalTrials.gov/show/NCT00796809 |
Completed |
University of Arizona |
2008-06-30 |
| NCT00006333 |
Study of Arthritis and Related Conditions |
https://ClinicalTrials.gov/show/NCT00006333 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001885 |
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00001885 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001678 |
Genetics of Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00001678 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001884 |
Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00001884 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |